Cadence Neuroscience raises $26M for epilepsy neuromod therapy
Neurmodulation technology developer Cadence Neuroscience announced that it secured $26 million in a Series B financing round.
Source: massdevice.com
Stay updated with breaking news from Kent Leyde. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Neurmodulation technology developer Cadence Neuroscience announced that it secured $26 million in a Series B financing round.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- Cadence Neuroscience announced today that it has secured $26 million in Series B financing. The round was led by Angelini Lumira Biosciences...